California Lawyer Features Burke's Participation in White Collar Defense Roundtable
March 13, 2014
California Lawyer Magazine
Partner Frank Burke was part of a wide-ranging roundtable discussion among senior defense attorneys and a federal prosecutor on emerging trends in white collar defense which was featured in the March 2014 edition of California Lawyer Magazine. The panel covered trends in residential mortgage backed securities, health care fraud, off-label pharmaceutical marketing, financial industry fraud, and emerging investigation techniques.
Regarding the proliferation of government prosecutions and False Claims Act whistleblower cases in health care and life sciences, Frank noted that “We’ve got a Medicare Fraud Strike Force and the Department of Health and Human Services at the federal level; at the state level we’ve got Medicaid fraud control units…[O]n top of all that you have whistleblowers… So the combination of very active state and federal enforcement and regulatory agencies and whistleblowers has led to a real explosion that I don’t think is going to abate anytime soon. Health care is such a large percentage of the economy.”
Regarding FCPA trends, Frank noted prosecutions of pharmaceutical and medical device makers concerning payments to doctors and hospitals in several foreign countries, and noted: “We’re also seeing more emphasis on prosecutions of foreign companies, which requires finding pieces of U.S. jurisdiction, either by charging them with conspiracy to act with a U.S. company, or perhaps payments that flowed through U.S. bank accounts, or e-mails sent through computers located on U.S. soil.”
Regarding the proliferation of government prosecutions and False Claims Act whistleblower cases in health care and life sciences, Frank noted that “We’ve got a Medicare Fraud Strike Force and the Department of Health and Human Services at the federal level; at the state level we’ve got Medicaid fraud control units…[O]n top of all that you have whistleblowers… So the combination of very active state and federal enforcement and regulatory agencies and whistleblowers has led to a real explosion that I don’t think is going to abate anytime soon. Health care is such a large percentage of the economy.”
Regarding FCPA trends, Frank noted prosecutions of pharmaceutical and medical device makers concerning payments to doctors and hospitals in several foreign countries, and noted: “We’re also seeing more emphasis on prosecutions of foreign companies, which requires finding pieces of U.S. jurisdiction, either by charging them with conspiracy to act with a U.S. company, or perhaps payments that flowed through U.S. bank accounts, or e-mails sent through computers located on U.S. soil.”
Related News
May 8, 2026
In the News
Shannon Goff Kukulka Highlighted Across Media for Foley Arrival
Foley & Lardner LLP partner Shannon Goff Kukulka is featured across media for her recent arrival to the firm's Nashville office.
May 8, 2026
In the News
Gregory Husisian Shares Insight on US Trade Court Tariff Ruling
Foley & Lardner LLP partner Gregory Husisian was quoted in Logistics Management’s article, “CIT Court Rules White House’s 10% Tariffs Not Lawful,” exploring the recent U.S. Court of International Trade decision.
May 6, 2026
In the News
Nicholas Johnson Interviewed on Oregon's EPR Rules, Challenges for Manufacturers
Foley & Lardner LLP senior counsel Nicholas Johnson appeared on KPNW Radio's “Wake up Call” to discuss Oregon's Extended Producer Responsibility (EPR) recycling law and what ongoing challenges to the law mean for manufacturer compliance, enforcement, and potential fee recovery.